Cargando…
Targeted Radiation and Immune Therapies—Advances and Opportunities for the Treatment of Prostate Cancer
Prostate cancer is the most diagnosed malignancy in men in the United States and the second leading cause of cancer-related death. For localized disease, radiation therapy is a standard treatment that is often curative. For metastatic disease, radiation therapy has been primarily used for palliation...
Autores principales: | Muralidhar, Anusha, Potluri, Hemanth K., Jaiswal, Tanya, McNeel, Douglas G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9863141/ https://www.ncbi.nlm.nih.gov/pubmed/36678880 http://dx.doi.org/10.3390/pharmaceutics15010252 |
Ejemplares similares
-
Vaccines as treatments for prostate cancer
por: Rastogi, Ichwaku, et al.
Publicado: (2023) -
Role of B cells as antigen presenting cells
por: Rastogi, Ichwaku, et al.
Publicado: (2022) -
Treatment Combinations with DNA Vaccines for the Treatment of Metastatic Castration-Resistant Prostate Cancer (mCRPC)
por: Gamat-Huber, Melissa, et al.
Publicado: (2020) -
Sipuleucel-T: immunotherapy for advanced prostate cancer
por: Olson, Brian M, et al.
Publicado: (2011) -
Antibody profiling of patients with prostate cancer reveals differences in antibody signatures among disease stages
por: Potluri, Hemanth K, et al.
Publicado: (2020)